CRESCENT BIOPHARMA, INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
CRESCENT BIOPHARMA, INC. (CBIO) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $62.96 million as of 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2016-02-29
- 2015-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $62.96M.
- 2014-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $55.01M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2015-12-31 | $62.96M 10-K · filed 2016-02-29 |
| 2014-12-31 | $55.01M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |